Brian Stauffer
Has grant
Division Chief, Cardiology NonInvasive
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Brian Stauffer is the Division Chief of Cardiology NonInvasive at Denver Health & Hospital Authority in the United States. His research focuses on cardiovascular health, exploring topics such as heart failure representation in exercise trials, the therapeutic effects of elamipretide, and the impact of gonadal status on artery stiffness. Additionally, he investigates the role of exercise training in mitigating cardiovascular risks among diverse populations and the mechanisms underlying age-related endothelial dysfunction.
Recent Grants
Grant: Close
Cardiolipin Mechanisms Underlying Mitochondrial Dysfunction in the Heart
Open Date: 2023-07-01
Close Date: 2025-06-30
Grant: Close
Bioenergetics and Myofibril Function in Pediatric Dilated Cardiomyopathy
Open Date: 2019-07-01
Close Date: 2022-06-30
Grant: Close
Molecular and Functional Mechanisms of Pediatric Heart Failure
Open Date: 2011-12-01
Close Date: 2016-11-30
Grant: Close
Molecular and Functional Mechanisms of Pediatric Heart Failure
Open Date: 2011-12-01
Close Date: 2016-11-30
Grant: Close
Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure
Open Date: 2009-09-01
Close Date: 2011-08-31
Articles (10)
Year:
2026
Year:
2025
Year:
2024
Year:
2024
Year:
2023
microRNAs (miRs) are small non-coding single-stranded RNAs that regulate gene expression. We previously evaluated expression of miRs in the cardiac tissue of children with dilated cardiomyopathy (DCM) using miRNA-seq. However, a comparative analysis of serum and cardiac miRs has not been performed in this population. The current study aimed to evaluate miR levels in the serum of pediatric DCM patients compared to healthy non-failing (NF) donor controls and investigate the association between miR levels in tissue and sera from the same pediatric DCM patients. Defining the relationship between serum and tissue miRs may allow the use of circulating miRs as surrogate markers of cardiac miRs. miR levels were investigated through miR-array in sera [n = 10 NF, n = 12 DCM] and miR-seq in tissue (n = 10 NF, n = 12 DCM). Pathway analysis was investigated using the miR enrichment analysis and annotation tool (miEAA) for the five miRs commonly dysregulated in the sera and tissue of pediatric DCM patients. Functional analysis of miRs commonly dysregulated in the sera and tissue of pediatric DCM patients suggests altered pathways related to cell growth, differentiation and proliferation, inflammation, mitochondrial function, and metabolism. These findings suggest that circulating miRs could reflect altered levels of cardiac tissue miRs.
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Collaborators (8)
CHRISTOPHER DESOUZA
University of Colorado Boulder
Matthew Armstrong
Assistant Professor
Syracuse University
Lyndsey DuBose
Assistant Professor Adjoint
University of Colorado Anschutz Medical Campus
Megan M. Wenner
-
Sydney Shuff
Professional Research Assistant
University of Colorado Boulder
Kerrie L. Moreau
University of Colorado Anschutz Medical Campus
Anastacia Garcia
Assistant Professor
University of Colorado Anschutz Medical Campus
Carmen C. Sucharov
University of Colorado School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.